Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Assignee

• Bristol-Myers Squibb

Inventors

• Ryan M. Moslin (16 patents)
• David S. Weinstein (37 patents)
• Stephen T. Wrobleski (49 patents)
• John S. Tokarski (37 patents)
• Amit Kumar (315 patents)
• Douglas G. Batt (54 patents)
• Shuqun Lin (18 patents)
• Chunjian Liu (49 patents)
• Steven H. Spergel (40 patents)
• Yanlei Zhang (8 patents)
• Qingjie Liu (29 patents)

View full patent text on Google Patents →